Literature DB >> 24526626

Genome Sequence of Fusobacterium nucleatum Strain W1481, a Possible New Subspecies Isolated from a Periodontal Pocket.

Mia Yang Ang1, David Dymock, Joon Liang Tan, Ming Hang Thong, Qin Kai Tan, Guat Jah Wong, Ian C Paterson, Siew Woh Choo.   

Abstract

Fusobacterium nucleatum is a bacterial species commonly detected in dental plaque within the human oral cavity, with some strains associated with periodontal disease, one of the most common clinical bacterial infections in the human body. The exact mechanisms of its pathogenesis are still not completely understood. In this study, we present the genome sequence and annotation of F. nucleatum strain W1481, isolated from a periodontal pocket of a dental patient at the University of Bristol, United Kingdom, the 16S rRNA gene sequencing of which showed it to be markedly different from the five previously named subspecies.

Entities:  

Year:  2014        PMID: 24526626      PMCID: PMC3924358          DOI: 10.1128/genomeA.00009-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Fusobacterium nucleatum is an anaerobic, Gram-negative, and nonsporulating bacterium associated with a wide spectrum of human infections and diseases (1). This species is often found in the oral cavity, as well as in gastrointestinal and genitourinary tracts in humans (2, 3). Recent studies have shown that F. nucleatum causes localized infections, such as tonsillitis, peritonsillar abscess, septicemia, and brain, liver, and lung abscesses (4). F. nucleatum is more frequently found in the periodontal pocket than in other sites (5), and it has been shown previously that different isolates from different subgroups vary in their pathogenicities and levels of disease activity (6). The species has been subdivided into five subspecies, F. nucleatum subsp. nucleatum, F. nucleatum subsp. polymorphum, F. nucleatum subsp. animalis, F. nucleatum subsp. fusiforme, and F. nucleatum subsp. vincentii (7), based on DNA-DNA hybridization comparisons and phenotypic characteristics (8). The representative genome sequences are available for each subspecies (9–16). In this study, we shotgun sequenced the genome of F. nucleatum strain W1481, which was isolated in Cardiff, United Kingdom, in December 1986 from an 8-mm periodontal pocket in a patient with chronic periodontitis, using the Illumina HiSeq 2000 sequencing platform. Based on 16S rRNA and comparative genomic analyses, this strain may represent a new subspecies of F. nucleatum. The generated raw genome reads underwent de novo assembly using CLC Genomics Workbench version 5.1.5. The assembly of the reads resulted in 186 contigs, with an N50 contig size of 44,334 bp. The smallest contig is 418 bp, whereas the largest contig is 135,502 bp. The size of the sequenced genome is 2,477,971 bp, with a G+C composition of 27.6%. The sequenced genome of F. nucleatum W1481 was annotated using the Rapid Annotations using Subsystems Technology (RAST) pipeline (17). RAST predicted 2,163 coding sequences (CDSs) and 56 RNAs in the genome. RAST functional annotation analysis revealed that most of these genes are involved in basic functions, such as cofactor, vitamin, prosthetic group, and pigment synthesis (161 genes), DNA metabolism (56 genes), RNA metabolism (46 genes), and amino acid and derivative synthesis (125 genes). No genes were predicted to be in the functional category of phages, prophages, transposable elements, or plasmids. Genomic islands (GIs) are clusters of genes in prokaryotic genomes of probable horizontal origin and are often associated with microbial adaptations of medical or environmental interest (18). Using the IslandViewer software (19), we predicted 6 putative GIs in the genome of F. nucleatum W1481. An examination of the GIs revealed the presence of genes involved in clustered regularly interspaced short palindromic repeats (CRISPRs) and the restriction-modification (RM) and toxin-antitoxin (TA) systems. According to Makarova et al. (20), all these are defense islands of prokaryotic genomes, which confer resistance to exogenous genetic elements, such as plasmids and phages. PHAST software (21) analysis showed that there are no prophages in the genome of F. nucleatum W1481. Therefore, we suggest that the presence of RM and TA systems and CRISPR-associated genes (Cas) in the GIs might confer resistance to the integration of phages into the genome. In conclusion, we report the genome of F. nucleatum W1481. The addition of this new genome may help achieve better insights into the biology, evolution, diversity, and pathogenicity of this oral pathogen.

Nucleotide sequence accession number.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. AXUR00000000.
  20 in total

1.  Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host.

Authors:  Jaclyn Strauss; Gilaad G Kaplan; Paul L Beck; Kevin Rioux; Remo Panaccione; Rebekah Devinney; Tarah Lynch; Emma Allen-Vercoe
Journal:  Inflamm Bowel Dis       Date:  2011-01-13       Impact factor: 5.325

Review 2.  Fusobacterial infections: clinical spectrum and incidence of invasive disease.

Authors:  Paul J Huggan; David R Murdoch
Journal:  J Infect       Date:  2008-09-20       Impact factor: 6.072

3.  Distribution and frequency of Fusobacterium nucleatum subspecies in the human oral cavity.

Authors:  S E Gharbia; H N Shah; P A Lawson; M Haapasalo
Journal:  Oral Microbiol Immunol       Date:  1990-12

4.  Draft genome sequence of Fusobacterium nucleatum ChDC F128, isolated from a periodontitis lesion.

Authors:  Soon-Nang Park; Si-Won Kong; Hwa-Sook Kim; Mo-Se Park; Jee-Won Lee; Eugene Cho; Yun Kyong Lim; Mi-Hwa Choi; Young-Hyo Chang; Jeong Hwan Shin; Hong-Seog Park; Sang-Haeng Choi; Joong-Ki Kook
Journal:  J Bacteriol       Date:  2012-11       Impact factor: 3.490

5.  The use of allozyme electrophoresis to assess genetic heterogeneity among previously subspeciated isolates of Fusobacterium nucleatum.

Authors:  M L Morris; R H Andrews; A H Rogers
Journal:  Oral Microbiol Immunol       Date:  1996-02

6.  An analysis of the subgingival microflora in randomly selected subjects.

Authors:  P N Papapanou; A Sellén; J L Wennström; G Dahlén
Journal:  Oral Microbiol Immunol       Date:  1993-02

7.  PHAST: a fast phage search tool.

Authors:  You Zhou; Yongjie Liang; Karlene H Lynch; Jonathan J Dennis; David S Wishart
Journal:  Nucleic Acids Res       Date:  2011-06-14       Impact factor: 16.971

8.  Genome sequence of Fusobacterium nucleatum subspecies polymorphum - a genetically tractable fusobacterium.

Authors:  Sandor E Karpathy; Xiang Qin; Jason Gioia; Huaiyang Jiang; Yamei Liu; Joseph F Petrosino; Shailaja Yerrapragada; George E Fox; Susan Kinder Haake; George M Weinstock; Sarah K Highlander
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

9.  Draft Genome Sequence of Fusobacterium nucleatum subsp. animalis ChDC F324, Isolated from a Human Subgingival Plaque in the Republic of Korea.

Authors:  Soon-Nang Park; Eugene Cho; Hwa-Sook Kim; Dae-Soo Kim; Jaeeun Jung; Jeong-Hun Baek; Yun Kyong Lim; Eojin Jo; Young-Hyo Chang; Jeong Hwan Shin; Sang-Haeng Choi; Jihee Kang; Yongun Choi; Si-Won Kong; Sang-Eun Han; Hong-Seog Park; Hongik Kim; Joong-Ki Kook
Journal:  Genome Announc       Date:  2013-12-12

Review 10.  Comparative genomics of defense systems in archaea and bacteria.

Authors:  Kira S Makarova; Yuri I Wolf; Eugene V Koonin
Journal:  Nucleic Acids Res       Date:  2013-03-06       Impact factor: 16.971

View more
  2 in total

1.  FusoBase: an online Fusobacterium comparative genomic analysis platform.

Authors:  Mia Yang Ang; Hamed Heydari; Nick S Jakubovics; Mahafizul Imran Mahmud; Avirup Dutta; Wei Yee Wee; Guat Jah Wong; Naresh V R Mutha; Shi Yang Tan; Siew Woh Choo
Journal:  Database (Oxford)       Date:  2014-08-22       Impact factor: 3.451

2.  Comparative Genome Analysis of Fusobacterium nucleatum.

Authors:  Mia Yang Ang; Avirup Dutta; Wei Yee Wee; David Dymock; Ian C Paterson; Siew Woh Choo
Journal:  Genome Biol Evol       Date:  2016-10-05       Impact factor: 3.416

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.